Larson Financial Group’s Filana Therapeutics FLNA Stock Holding History

Larson Financial Group’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17	Hold	10	–	–	﹤0.01%	3587
2025 Q4	$20	Buy	+10	New	+$32	﹤0.01%	3410
2024 Q4	–	Sell	-100	Closed	-$2.94K	–	2886
2024 Q3	$2.94K	Hold	100	–	–	﹤0.01%	1781
2024 Q2	$1.24K	Hold	100	–	–	﹤0.01%	1668
2024 Q1	$2.03K	Hold	100	–	–	﹤0.01%	1359
2023 Q4	$2.25K	Hold	100	–	–	﹤0.01%	1352
2023 Q3	$1.66K	Hold	100	–	–	﹤0.01%	1392
2023 Q2	$2.45K	Hold	100	–	–	﹤0.01%	1239
2023 Q1	$2.41K	Buy	100 +61	+156%	+$1.69K	﹤0.01%	1218
2022 Q4	$1.15K	Hold	39	–	–	﹤0.01%	1269
2022 Q3	$2K	Buy	+39	New	+$1.05K	﹤0.01%	1139
2021 Q4	–	Sell	-42	Closed	-$3K	–	1161
2021 Q3	$3K	Buy	+42	New	+$3.5K	﹤0.01%	752

Other funds holding FLNA

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Larson Financial Group's FLNA Position: Q1 2026 in Review

Larson Financial Group held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 10 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #3587.

Larson Financial Group first reported a position in FLNA in Q3 2021 and has held it in 12 quarters since. The position peaked at $3K in Q3 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

Larson Financial Group held 10 shares of Filana Therapeutics worth $17 as of Q1 2026.
Larson Financial Group left its Filana Therapeutics share count unchanged in Q1 2026.
Filana Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3587 holding.
Larson Financial Group first reported a position in Filana Therapeutics in Q3 2021 and has held it in 12 quarters since.
Larson Financial Group's Filana Therapeutics position peaked at $3K in Q3 2021.
101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.